TY  - JOUR
AU  - Macauda, Angelica
AU  - Castelli, Eleonora
AU  - Buda, Gabriele
AU  - Pelosini, Matteo
AU  - Butrym, Aleksandra
AU  - Watek, Marzena
AU  - Kruszewski, Marcin
AU  - Vangsted, Annette Juul
AU  - Rymko, Marcin
AU  - Jamroziak, Krzysztof
AU  - Abildgaard, Niels
AU  - Haastrup, Eva Kannik
AU  - Mazur, Grzegorz
AU  - Ríos, Rafael
AU  - Jurczyszyn, Artur
AU  - Zawirska, Daria
AU  - Dudziński, Marek
AU  - Raźny, Małgorzata
AU  - Dutka, Magdalena
AU  - Tomczak, Waldemar
AU  - Suska, Anna
AU  - Druzd-Sitek, Agnieszka
AU  - Marques, Herlander
AU  - Petrini, Mario
AU  - Markiewicz, Miroslaw
AU  - Martinez-Lopez, Joaquin
AU  - Ebbesen, Lene Hyldahl
AU  - Iskierka-Jażdżewska, Elżbieta
AU  - Sainz, Juan
AU  - Canzian, Federico
AU  - Campa, Daniele
PY  - 2018
DO  - 10.1111/bjh.15521
UR  - http://hdl.handle.net/10668/12804
T2  - British journal of haematology
AB  - Over the past four decades, remarkable progress has been made in the treatment and prognosis of multiple myeloma (MM), although it remains an incurable disease. Chemotherapy resistance is a major hurdle for treatment efficacy. Drug resistance can be...
LA  - en
KW  - genetic polymorphisms
KW  - multiple myeloma
KW  - overall survival
KW  - progression-free survival
KW  - xenobiotic transporter
KW  - Aged
KW  - Carrier Proteins
KW  - Constitutive Androstane Receptor
KW  - Disease-Free Survival
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Linkage Disequilibrium
KW  - Male
KW  - Middle Aged
KW  - Multidrug Resistance-Associated Protein 2
KW  - Multiple Myeloma
KW  - Neoplasm Proteins
KW  - Polymorphism, Single Nucleotide
KW  - Retrospective Studies
KW  - Survival Rate
TI  - Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
TY  - research article
VL  - 183
ER  -